We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Peel-and-Sniff Cards Could Make Smell Test Single Best Predictor of Being COVID-19 Positive

By LabMedica International staff writers
Posted on 14 Oct 2020
Sensory scientists are encouraging smell checks to fight the COVID-19 spread and are also developing peel-and-sniff cards to supplement other COVID-19 testing and surveillance efforts.

With mounting scientific evidence that anosmia, or loss of smell, is one of the most specific symptoms of COVID-19 infection, sensory scientists at the Pennsylvania State University (University Park, PA, USA) are making efforts to raise awareness about the link between COVID-19 and smell loss. More...
Previous research has found that certain cells at the top of the nasal cavity harbor proteins that the coronavirus targets when invading these cells. The local disruption that occurs is different from the loss of smell that occurs with the common cold, which is due to blockage of the nasal passages. With COVID-19, many patients lose the ability to smell without being stuffy or congested.

The sensory scientists at Penn State believe that greater public awareness of the link between COVID-19 and sudden smell loss could assist in identifying pre-symptomatic or otherwise asymptomatic individuals, which might help contain the virus and ease the burden on sometimes-overwhelmed health care facilities. Additionally, the scientists are members of an international research team, the Global Consortium for Chemosensory Research, that has studied the link between COVID-19 and smell loss. Collaborating with more than 600 clinicians, scientists and patient advocates in 40 countries in an ongoing study, the Penn State researchers so far have surveyed more than 40,000 participants who suffered from recent respiratory illness. The scientists are now developing peel-and-sniff cards that will be distributed to the Penn State community in the near future to supplement other COVID-19 testing and surveillance efforts.

"Our results showed that of all common symptoms of COVID-19, sudden smell loss was the single best predictor of being positive for the disease," said John Hayes, professor of food science and director of the Penn State Sensory Evaluation Center. "Other studies are finding similar results. Together, this suggests that sudden smell loss is a better predictor than fever or cough."

Related Links:
Pennsylvania State University


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple daily blood test could help critically ill sepsis patients stop antibiotics sooner, reducing overuse and potentially helping combat antibiotic resistance (Image Credit: Adobe Stock)

Daily Blood Biomarker Testing May Help Guide Earlier Antibiotic Stopping in Sepsis

Sepsis is a life-threatening condition caused by the body’s overwhelming response to infection and accounts for thousands of deaths each year. In intensive care, concern about stopping treatment too early... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.